227 related articles for article (PubMed ID: 29018243)
1. 6E11, a highly selective inhibitor of Receptor-Interacting Protein Kinase 1, protects cells against cold hypoxia-reoxygenation injury.
Delehouzé C; Leverrier-Penna S; Le Cann F; Comte A; Jacquard-Fevai M; Delalande O; Desban N; Baratte B; Gallais I; Faurez F; Bonnet MC; Hauteville M; Goekjian PG; Thuillier R; Favreau F; Vandenabeele P; Hauet T; Dimanche-Boitrel MT; Bach S
Sci Rep; 2017 Oct; 7(1):12931. PubMed ID: 29018243
[TBL] [Abstract][Full Text] [Related]
2. Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis.
Le Cann F; Delehouzé C; Leverrier-Penna S; Filliol A; Comte A; Delalande O; Desban N; Baratte B; Gallais I; Piquet-Pellorce C; Faurez F; Bonnet M; Mettey Y; Goekjian P; Samson M; Vandenabeele P; Bach S; Dimanche-Boitrel MT
FEBS J; 2017 Sep; 284(18):3050-3068. PubMed ID: 28715128
[TBL] [Abstract][Full Text] [Related]
3. Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3.
Chen X; Zhuang C; Ren Y; Zhang H; Qin X; Hu L; Fu J; Miao Z; Chai Y; Liu ZG; Zhang H; Cai Z; Wang HY
Br J Pharmacol; 2019 Jun; 176(12):2095-2108. PubMed ID: 30825190
[TBL] [Abstract][Full Text] [Related]
4. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis.
Fauster A; Rebsamen M; Huber KV; Bigenzahn JW; Stukalov A; Lardeau CH; Scorzoni S; Bruckner M; Gridling M; Parapatics K; Colinge J; Bennett KL; Kubicek S; Krautwald S; Linkermann A; Superti-Furga G
Cell Death Dis; 2015 May; 6(5):e1767. PubMed ID: 25996294
[TBL] [Abstract][Full Text] [Related]
5. Protein-Bound Polysaccharides from
Pawlikowska M; Jędrzejewski T; Brożyna AA; Wrotek S
Cell Physiol Biochem; 2020 Jun; 54(4):591-604. PubMed ID: 32531147
[TBL] [Abstract][Full Text] [Related]
6. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis.
Hou J; Ju J; Zhang Z; Zhao C; Li Z; Zheng J; Sheng T; Zhang H; Hu L; Yu X; Zhang W; Li Y; Wu M; Ma H; Zhang X; He S
Cell Death Dis; 2019 Jun; 10(7):493. PubMed ID: 31235688
[TBL] [Abstract][Full Text] [Related]
8. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
[TBL] [Abstract][Full Text] [Related]
9. 24(S)-Hydroxycholesterol induces RIPK1-dependent but MLKL-independent cell death in the absence of caspase-8.
Vo DK; Urano Y; Takabe W; Saito Y; Noguchi N
Steroids; 2015 Jul; 99(Pt B):230-7. PubMed ID: 25697054
[TBL] [Abstract][Full Text] [Related]
10. The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases.
Qin X; Hu L; Shi SN; Chen X; Zhuang C; Zhang W; Jitkaew S; Pang X; Yu J; Tan YX; Wang HY; Cai Z
Biochem Pharmacol; 2020 Jul; 177():113947. PubMed ID: 32247850
[TBL] [Abstract][Full Text] [Related]
11. Identification and Characterization of NTB451 as a Potential Inhibitor of Necroptosis.
In EJ; Lee Y; Koppula S; Kim TY; Han JH; Lee KH; Kang TB
Molecules; 2018 Nov; 23(11):. PubMed ID: 30400632
[TBL] [Abstract][Full Text] [Related]
12. Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation.
Shindo R; Kakehashi H; Okumura K; Kumagai Y; Nakano H
Biochem Biophys Res Commun; 2013 Jun; 436(2):212-6. PubMed ID: 23727581
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury.
Martens S; Jeong M; Tonnus W; Feldmann F; Hofmans S; Goossens V; Takahashi N; Bräsen JH; Lee EW; Van der Veken P; Joossens J; Augustyns K; Fulda S; Linkermann A; Song J; Vandenabeele P
Cell Death Dis; 2017 Jun; 8(6):e2904. PubMed ID: 28661484
[TBL] [Abstract][Full Text] [Related]
14. Necrostatin-1 Improves Long-term Functional Recovery Through Protecting Oligodendrocyte Precursor Cells After Transient Focal Cerebral Ischemia in Mice.
Chen Y; Zhang L; Yu H; Song K; Shi J; Chen L; Cheng J
Neuroscience; 2018 Feb; 371():229-241. PubMed ID: 29247776
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor.
Delanghe T; Huyghe J; Lee S; Priem D; Van Coillie S; Gilbert B; Choi SM; Vandenabeele P; Degterev A; Cuny GD; Dondelinger Y; Bertrand MJM
Cell Death Dis; 2021 Jul; 12(7):699. PubMed ID: 34262020
[TBL] [Abstract][Full Text] [Related]
16. TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation.
Jouan-Lanhouet S; Arshad MI; Piquet-Pellorce C; Martin-Chouly C; Le Moigne-Muller G; Van Herreweghe F; Takahashi N; Sergent O; Lagadic-Gossmann D; Vandenabeele P; Samson M; Dimanche-Boitrel MT
Cell Death Differ; 2012 Dec; 19(12):2003-14. PubMed ID: 22814620
[TBL] [Abstract][Full Text] [Related]
17. RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis.
Kearney CJ; Cullen SP; Clancy D; Martin SJ
FEBS J; 2014 Nov; 281(21):4921-34. PubMed ID: 25195660
[TBL] [Abstract][Full Text] [Related]
18. Ischemia-reperfusion induces death receptor-independent necroptosis via calpain-STAT3 activation in a lung transplant setting.
Kim H; Zamel R; Bai XH; Lu C; Keshavjee S; Keshavjee S; Liu M
Am J Physiol Lung Cell Mol Physiol; 2018 Oct; 315(4):L595-L608. PubMed ID: 30024306
[TBL] [Abstract][Full Text] [Related]
19. ATP-Competitive MLKL Binders Have No Functional Impact on Necroptosis.
Ma B; Marcotte D; Paramasivam M; Michelsen K; Wang T; Bertolotti-Ciarlet A; Jones JH; Moree B; Butko M; Salafsky J; Sun X; McKee T; Silvian LF
PLoS One; 2016; 11(11):e0165983. PubMed ID: 27832137
[TBL] [Abstract][Full Text] [Related]
20. Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives.
Zhuang C; Chen F
J Med Chem; 2020 Feb; 63(4):1490-1510. PubMed ID: 31622096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]